Drug · DIN 02460017
DAPTOMYCIN FOR INJECTION
SINGLE-USE VIAL
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since October 16, 2020.
- Drug Identification Number (DIN)
- 02460017
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Daptomycin J01XX09
- Class
- Human
- Record last updated
- August 13, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DAPTOMYCIN | 500 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 25, 2019: NOC 22685Abbreviated New Drug Submission (ANDS)
Other DINs named DAPTOMYCIN FOR INJECTION
- DIN 02490463 · Marketed
- DIN 02490838 · Marketed
- DIN 02460009 · Cancelled Pre Market
- DIN 02462117 · Cancelled Pre Market
- DIN 02494590 · Cancelled Post Market
- DIN 02511738 · Cancelled Pre Market
- DIN 02526743 · Cancelled Pre Market